| John Eric Player, DO | |
|
5668 E State St, Suite 1000, Rockford, IL 61108-2464 | |
| (815) 397-7900 | |
| (815) 397-7919 |
| Full Name | John Eric Player |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 5668 E State St, Rockford, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285965905 | NPI | - | NPPES |
| 61001 | Other | WI | DEAN HEALTH INSURANCE |
| 100008500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 54098-21 (Wisconsin) | Secondary |
| 208600000X | Surgery | 036.133344 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint James Hospital | Pontiac, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Doctors at Cincinnati Children's Hospital Medical Center want to remind parents about the importance of immunizing their children when preparing to send their children back to school.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
› Verified 6 days ago
| Entity Name | Pekin Prohealth Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932150299 PECOS PAC ID: 1951214576 Enrollment ID: O20031110000647 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Doctors at Cincinnati Children's Hospital Medical Center want to remind parents about the importance of immunizing their children when preparing to send their children back to school.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
› Verified 6 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Doctors at Cincinnati Children's Hospital Medical Center want to remind parents about the importance of immunizing their children when preparing to send their children back to school.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Eric Player, DO 5668 E State St, Suite 1000, Rockford, IL 61108-2464 Ph: (815) 397-7900 | John Eric Player, DO 5668 E State St, Suite 1000, Rockford, IL 61108-2464 Ph: (815) 397-7900 |
News Archive
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
Doctors at Cincinnati Children's Hospital Medical Center want to remind parents about the importance of immunizing their children when preparing to send their children back to school.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
› Verified 6 days ago
William James Cowden, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2300 N Rockton Ave, Suite 304, Rockford, IL 61103 Phone: 815-964-3333 Fax: 815-964-3134 | |
Jeffrey Andrew Barteau, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 5668 E State St, Rockford, IL 61108 Phone: 815-229-7580 Fax: 815-229-7585 | |
Dacia Aurelia Pickering, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5668 E State St, #2, Rockford, IL 61108 Phone: 815-397-7900 Fax: 815-397-4839 | |
Arvind Mahatme, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7180 Spring Brook Rd, Rockford, IL 61114 Phone: 815-971-2299 Fax: 815-971-9959 | |
Dr. Andrew Paul Hoffman, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 5668 E State St, Rockford, IL 61108 Phone: 815-229-7580 | |
Dr. Jacinto Garcia Obregon, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 535 Roxbury Rd, Rockford, IL 61107 Phone: 815-398-0175 Fax: 815-398-9587 | |
Dr. David M Cheng, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2350 N Rockton Ave, Rmb 1st Floor, Rockford, IL 61103 Phone: 815-971-2485 |